Michael Kuligowski
3Patents
1h-index
4Co-inventors
30Inventor score
Filing activity: Sep 4, 2020 → Oct 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11590137B2 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Human Necessities | 1 | Active |
| US11510923B2 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Human Necessities | 1 | Active |
| US12396993B2 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.